1. Home
  2. CALC vs MNDO Comparison

CALC vs MNDO Comparison

Compare CALC & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • MNDO
  • Stock Information
  • Founded
  • CALC 2011
  • MNDO 1995
  • Country
  • CALC United States
  • MNDO Israel
  • Employees
  • CALC N/A
  • MNDO N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • MNDO EDP Services
  • Sector
  • CALC Health Care
  • MNDO Technology
  • Exchange
  • CALC Nasdaq
  • MNDO Nasdaq
  • Market Cap
  • CALC 36.0M
  • MNDO 39.9M
  • IPO Year
  • CALC N/A
  • MNDO 2000
  • Fundamental
  • Price
  • CALC $2.35
  • MNDO $2.10
  • Analyst Decision
  • CALC Strong Buy
  • MNDO
  • Analyst Count
  • CALC 5
  • MNDO 0
  • Target Price
  • CALC $18.20
  • MNDO N/A
  • AVG Volume (30 Days)
  • CALC 31.5K
  • MNDO 46.2K
  • Earning Date
  • CALC 03-27-2025
  • MNDO 03-05-2025
  • Dividend Yield
  • CALC N/A
  • MNDO 11.37%
  • EPS Growth
  • CALC N/A
  • MNDO N/A
  • EPS
  • CALC N/A
  • MNDO 0.23
  • Revenue
  • CALC N/A
  • MNDO $21,856,000.00
  • Revenue This Year
  • CALC N/A
  • MNDO N/A
  • Revenue Next Year
  • CALC N/A
  • MNDO N/A
  • P/E Ratio
  • CALC N/A
  • MNDO $9.05
  • Revenue Growth
  • CALC N/A
  • MNDO 2.27
  • 52 Week Low
  • CALC $2.05
  • MNDO $1.70
  • 52 Week High
  • CALC $6.27
  • MNDO $2.28
  • Technical
  • Relative Strength Index (RSI)
  • CALC 35.06
  • MNDO 56.56
  • Support Level
  • CALC $2.36
  • MNDO $2.07
  • Resistance Level
  • CALC $2.66
  • MNDO $2.13
  • Average True Range (ATR)
  • CALC 0.24
  • MNDO 0.05
  • MACD
  • CALC -0.02
  • MNDO 0.00
  • Stochastic Oscillator
  • CALC 4.13
  • MNDO 78.57

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.

Share on Social Networks: